Related Experiment Video

Updated: Aug 22, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

The promise of targeted therapy: cancer drugs become more specific

Ena Segota1, Ronald M Bukowski

  • 1Taussig Cancer Center, Cleveland Clinic Foundation, OH 44195, USA.

Cleveland Clinic Journal of Medicine
|August 24, 2004
PubMed

Insights

New targeted cancer therapies offer more effective treatments with fewer side effects than traditional chemotherapy. These molecular and genetic drugs show promise, with several already FDA-approved and many more in clinical trials.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Traditional chemotherapy agents exhibit significant toxicity.
  • Emerging targeted therapies offer a more precise approach to cancer treatment.
  • Molecular and genetic strategies are revolutionizing cancer drug development.

Purpose of the Study:

  • To review the current landscape of targeted cancer therapies.
  • To highlight the potential of novel molecular and genetic drugs.
  • To discuss the implications of targeted agents in clinical practice.

Main Methods:

  • Literature review of targeted cancer therapies.
  • Analysis of FDA-approved molecular and genetic agents.
  • Overview of ongoing clinical trials for novel cancer drugs.

Main Results:

  • Several targeted agents are approved by the US Food and Drug Administration (FDA) for malignancies.
  • Numerous targeted drugs are currently undergoing clinical trials.
  • These therapies demonstrate potential for increased efficacy and reduced side effects.

Conclusions:

  • Targeted cancer therapies represent a significant advancement over traditional chemotherapy.
  • Molecular and genetic approaches hold promise for more effective and safer cancer treatments.
  • The continued development and approval of targeted agents are transforming oncology care.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.